Syndax Pharmaceuticals Non-Current Deferred Revenue (Quarterly) Trends

Syndax Pharmaceuticals, Inc. (SNDX)

20.90 +0.43 (+2.10%) USD | NASDAQ | Jan 14, 12:12

View Non-Current Deferred Revenue (Quarterly) for SNDX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Arcutis Biotherapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Puma Biotechnology, Inc.	--
Krystal Biotech, Inc.	--
Sutro Biopharma, Inc.	Upgrade